Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01712555 · ClinicalTrials.gov registry record · NA

Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets

A NA study of Orbital Atrophy, sponsored by Fox, Donald Munro, M.D., P.C..

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT01712555: Completed NA study of Orbital Atrophy, sponsored by Fox, Donald Munro, M.D., P.C..

NCT01712555 is a NA study of Orbital Atrophy that has completed, run by Fox, Donald Munro, M.D., P.C.. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01712555, a NA study of Orbital Atrophy, has completed, sponsored by Fox, Donald Munro, M.D., P.C..

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

After people lose an eye, for whatever reason, they often experience fat atrophy of the tissues in the orbit. This leads to a sunken appearance that is often not correctable by a cosmetic shell prosthesis. Current techniques to correct this deformity are inadequate/ invasive. Injection of various gels (Restylane, Radiesse) are temporary had have their own disadvantages. This study seeks to demonstrate an improvement in the retention of injected autologous fat by mixing in autologous PRP (platelet rich plasma).

Primary Outcome

Non contrast MRIs of the orbits are obtained before, immediately after, and one year after injection of autologous fat mixed with autologous PRP (platelet rich plasma)

Conditions Studied

Interventions

  • PROCEDURE autologous fat grafting with PRP to anophthalmic orbits

Study Locations (1)

New York

  • New York Eye and Ear Infirmary - New York

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2011-12
Est. Completion 2017-12-15
Phase NA
Fox, Donald Munro, M.D., P.C.

3 total trials

What the finished NCT01712555 record still lists

NCT01712555 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Orbital Atrophy appearing as the primary indexed condition, and to 1 intervention - of which autologous fat grafting with PRP to anophthalmic orbits is the first listed.

NCT01712555 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01712555 about?

NCT01712555 is a clinical study titled "Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets". After people lose an eye, for whatever reason, they often experience fat atrophy of the tissues in the orbit. This leads to a sunken appearance that is often not correctable by a cosmetic shell prosthesis. Current techniques to correct this deformity are inadequate/ invasive. Injection of various ge...

What is the current status of trial NCT01712555?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-12. Estimated completion is 2017-12-15.

What conditions does trial NCT01712555 study?

This clinical trial studies the following conditions: Orbital Atrophy.

What interventions are being tested in trial NCT01712555?

The interventions under investigation include: autologous fat grafting with PRP to anophthalmic orbits (PROCEDURE).

Who is sponsoring clinical trial NCT01712555?

This trial is sponsored by Fox, Donald Munro, M.D., P.C., which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01712555 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01712555's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01712555, the US trial registry maintained by the National Library of Medicine. NCT01712555 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.